Reason for request
Inclusion for an extension of indication
Clinical Benefit
| Substantial |
The actual benefit of VOTRIENT is substantial in th is indication. |
Clinical Added Value
| minor |
VOTRIENT has a minor IAB (level IV) in terms of efficacy compared with the current treatment strategy. |
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
LnLWyxDRNTHq9aLk
